Earth Science Tech shareholders approve reverse stock split and other strategic decisions
MIAMI, FL, Sept. 01, 2026 /CourierPR/ -- Earth Science Tech, Inc., a diversified holding company focusing on the health and wellness sector, recently concluded its first Annual Meeting of Stockholders. Held virtually on August 31, 2026, the meeting saw several key decisions that will shape the company’s future.
The shareholders approved a strategic decision to pursue a reverse stock split, valid for a period of 12 months. This move is contingent on the Board’s judgment that it is necessary to satisfy the minimum bid price requirements for an uplisting to a national securities exchange. The reverse split is designed to improve the company’s liquidity and market visibility, potentially enhancing investor confidence.
Another significant vote was on the retirement of the Series B Preferred Stock. Shareholders granted the Board’s independent Special Committee the authority to negotiate the retirement of these shares. This decision marks a shift in the company’s governance structure, eliminating the dual-class, super-voting control and aligning voting power more closely with the economic interests of all shareholders.
The company’s executive compensation structure also received shareholder approval. The structure is non-dilutive and consists of cash-only performance-based bonuses. Shareholders endorsed a three-year review cycle, validating the management’s approach to protecting shareholder equity by avoiding stock dilution.
All seven director nominees were re-elected to the Board for the upcoming year, ensuring continuity in leadership. Shareholders also ratified the appointment of Semple, Marchal & Cooper, LLP, as the company’s independent registered public accounting firm, reinforcing the company’s commitment to transparency and accountability.
For shareholders and interested investors, the company has made the full audio recording of the meeting available. The recording includes essential management guidance, detailed explanations of the strategic rationale behind the approved proposals, and a comprehensive Q&A session addressing shareholder inquiries. The recording can be accessed here.
Earth Science Tech, Inc., operates as a vertically integrated healthcare platform combining compounding pharmacy operations, telemedicine, clinical support, and direct-to-patient fulfillment. The company supports its healthcare operations with investments in real estate and asset management activities, as well as a consumer products business. The seamless integration of patient care, from consultation to fulfillment, forms the core of the company’s value proposition, achieved through the synergy of specialized subsidiaries.
The company’s strategic focus on building a diversified healthcare platform and its commitment to protecting shareholder equity are evident in the approved proposals. These decisions set the stage for future growth and operational efficiency, as the company aims to enhance its market position and shareholder value.